Discover the breakthroughs in oncology with my review of 2024’s most promising cancer drugs. From innovative treatments like Datopotamab Deruxtecan targeting lung cancer to Talquetamab's potential in multiple myeloma, this report highlights key advancements. Learn about Zolbetuximab's role in gastric cancer and the combination of Niraparib and Abiraterone Acetate in prostate cancer. Explore how these drugs are shaping the future of cancer treatment